Last reviewed · How we verify
NCT03566589
Effects of PS128 on Parkinsonian Symptoms
NA trial testing Lactobacillus plantarum PS128 in Parkinson Disease in 30 participants. Completed in 30 December 2018.
9 November 2018
Quick facts
| Lead sponsor | Professor Lu Neurological Clinic |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 2 July 2018 |
| Primary completion | 9 November 2018 |
| Estimated completion | 30 December 2018 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Lactobacillus plantarum PS128
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
Professor Lu Neurological Clinic
Who can join
Adults 40 to 80, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine the short term effects (12 Weeks) of Lactobacillus plantarum PS128 (PS128) on Parkinson's disease (PD) symptoms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03566589
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lactobacillus plantarum PS128
Trials testing the same drug.
- NCT03237078 — Lactobacillus Plantarum PS128 in Patients With Major Depressive Disorder and High Level of Inflammation · NA · unknown
- NCT04093960 — Escitalopram Plus PS128 vs. Escitalopram · Phase 4 · terminated
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Professor Lu Neurological Clinic trials
Trials by the same sponsor.
- NCT04722198 — Effects of Lactobacillus Plantarum PS128 on Symptoms of Early-onset Parkinson's Disease: a Pilot Study · NA · unknown
- NCT04722211 — Effects of Lactobacillus Plantarum PS128 on the Parkinsonian Symptoms in Parkinson's Disease. · NA · unknown
- NCT04389762 — PS128 May Improve Off Duration on Parkinson's Disease · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03566589 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Professor Lu Neurological Clinic
- Last refreshed: 10 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03566589.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing